INTRODUCTION

The coronavirus disease 2019 (COVID-19) pandemic has resulted in a decline in patients seeking outpatient medical care.1, 2 How COVID-19 has impacted patients seeking care for emergent conditions remains unclear, with emerging studies demonstrating a reduction in acute cardiovascular hospitalizations.3, 4 In this study, we examined the incidence of emergent medical, surgical, and obstetric hospitalizations at a tertiary referral center in Boston, MA.

METHODS

We identified all hospital admissions from a 651-bed hospital in Boston between January 1, 2019, and April 25, 2020. Primary discharge diagnoses were collected from hospital administrative databases and categorized using Agency for Healthcare Research and Quality Clinical Classification Software.5 COVID-19 hospitalizations were identified based on positive polymerase chain reaction testing or COVID-19-specific ICD-10 diagnoses coding (U071).

We examined the weekly incidence of overall admissions to medical, surgical, obstetric, and psychiatric services as well as hospitalizations for COVID-19 in 2020. We then examined the incidence of hospitalizations for emergent conditions including acute medical conditions, acute surgical conditions, chronic disease exacerbations, obstetric conditions, and COVID-19. We used t tests with two-sided P values < .05 for significance to compare the incidence of hospitalizations in the 6 weeks following the Boston COVID-19 public health emergency declaration (week of March 11, 2020) with the same period in 2019. We then conducted time series analyses comparing weekly hospitalization rates in the period prior to COVID-19 (January 1, 2019 to March 10, 2020) with the COVID-19 period (March 11, 2020 to April 28, 2020) using ordinary least squares regressions with Newey-West standard errors to account for autocorrelation. Analyses were conducted using Stata 14.1. This research was classified as exempt by the Beth Israel Deaconess Medical Center institutional review board.

RESULTS

Data from 12,935 hospitalizations from January 1, 2020, through April 28, 2020, were examined, including 7165 (55.4%) medical, 3189 (24.7%) surgical, 1807 (14.0%) obstetric, 175 (1.4%) psychiatric, and 599 (4.7%) COVID-19 hospitalizations. In total, 4840 (37.4%) hospitalizations were classified as emergent (Fig. 1).

Figure 1
figure 1

Weekly trends in hospitalizations. a Overall hospitalizations. b Emergent hospitalizations. Note: Overall hospitalizations categorized by specialty of discharging service. COVID-19 hospitalizations were identified by an International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10) code of “U071 COVID-19, virus identified” or positive COVID-19 polymerase chain reaction testing during hospitalization or up to 14 days prior to hospitalization. Emergent conditions categorized using AHRQ Clinical Classification Software Refined categorization of ICD-10 primary discharge diagnosis codes. Acute medical conditions include acute myocardial infarction; cardiac arrest and ventricular fibrillation; cardiac dysrhythmias; arterial dissections; endocarditis and endocardial disease; myocarditis and cardiomyopathy; pericarditis and pericardial disease; acute hemorrhagic cerebrovascular disease; cerebral infarction; transient cerebral ischemia; gastrointestinal hemorrhage; acute pulmonary embolism; acute phlebitis, thrombophlebitis; and thromboembolism. Acute surgical conditions include appendicitis and other appendiceal conditions; gastrointestinal and biliary perforation; intestinal obstruction and ileus; and peritonitis and intra-abdominal abscess, and initial encounters for traumatic injuries including fractures, dislocations, traumatic brain and spinal cord injury, open wounds, crush injuries, and burns. Chronic disease exacerbations include hospitalizations for asthma, chronic obstructive pulmonary disease and bronchiectasis, diabetes, and heart failure. A total of 93 patients (0.7%) were categorized as “Not coded” due to missing discharge diagnosis codes, as 37 remained hospitalized at the time of data collection and 56 lacked billing data.

Compared with the same 6-week period in 2019, there was a 35.1% decrease in weekly hospitalizations overall and 44.7% decrease in weekly non-COVID hospitalizations in the COVID-19 period. There were significantly fewer weekly hospitalizations for acute medical conditions (− 51.0%), acute surgical conditions (− 30.5%), chronic disease exacerbations (− 55.0%), and obstetric hospitalizations (− 12.9%) (Table 1).

Table 1 Time Series Analysis

In time series analysis, there were no significant trends in weekly hospitalization rates in the pre-COVID-19 period. During the week of the Boston public health emergency declaration, there was an immediate decrease in hospitalizations, overall, for acute medical conditions, and for chronic disease exacerbations. During the COVID period, there was a continued increase in COVID-19 hospitalizations and a decline in hospitalizations for acute surgical conditions, for chronic disease exacerbations, and for obstetric conditions (Table 1).

DISCUSSION

In this single-center study at a tertiary care center in Boston, we observed an immediate decline in the incidence of hospitalizations overall and for a variety of emergent medical and surgical conditions which corresponded with the initiation of local public health emergency measures, and this decline persisted throughout the next 6 weeks. These findings build on recent studies demonstrating a reduction in the incidence of acute cardiovascular hospitalizations3, 4 and a study which examined a smaller subset of acute conditions in the Veterans Affairs health system.6

This study relied on administrative coding and cannot explain the reasons for the observed reduction in the incidence of emergent hospitalizations which are likely multifactorial and may include individuals not seeking hospital care, individuals choosing to seek care at other hospitals, competing risk of hospitalization from COVID-19, geographic migration from Boston, and a reduction in underlying events.

Further population-based studies are needed to determine the impact of the COVID-19 pandemic on long-term outcomes of patients delaying care for acute and chronic conditions.